OFI Invest Asset Management increased its position in shares of Cigna Group (NYSE:CI - Free Report) by 8,357.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 33,070 shares of the health services provider's stock after acquiring an additional 32,679 shares during the quarter. OFI Invest Asset Management's holdings in Cigna Group were worth $9,102,000 as of its most recent SEC filing.
Several other large investors have also recently modified their holdings of the company. Pathway Financial Advisers LLC raised its stake in shares of Cigna Group by 2.3% during the 2nd quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider's stock worth $496,000 after acquiring an additional 34 shares in the last quarter. Armstrong Advisory Group Inc. raised its stake in shares of Cigna Group by 17.7% during the 3rd quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider's stock worth $65,000 after acquiring an additional 34 shares in the last quarter. HM Payson & Co. raised its stake in shares of Cigna Group by 0.9% during the 3rd quarter. HM Payson & Co. now owns 3,785 shares of the health services provider's stock worth $1,091,000 after acquiring an additional 35 shares in the last quarter. Carr Financial Group Corp raised its stake in shares of Cigna Group by 5.3% during the 3rd quarter. Carr Financial Group Corp now owns 709 shares of the health services provider's stock worth $204,000 after acquiring an additional 36 shares in the last quarter. Finally, Natural Investments LLC raised its stake in shares of Cigna Group by 2.0% during the 3rd quarter. Natural Investments LLC now owns 1,843 shares of the health services provider's stock worth $531,000 after acquiring an additional 36 shares in the last quarter. Institutional investors own 86.99% of the company's stock.
Cigna Group Stock Up 0.3%
CI stock opened at $278.27 on Friday. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. The firm's fifty day moving average is $276.40 and its 200 day moving average is $278.75. The firm has a market cap of $73.33 billion, a PE ratio of 12.55, a P/E/G ratio of 0.96 and a beta of 0.26.
Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping analysts' consensus estimates of $7.88 by $0.20. The business had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company's revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, research analysts forecast that Cigna Group will post 29.77 EPS for the current year.
Cigna Group Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th were given a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. This is an increase from Cigna Group's previous quarterly dividend of $1.51. The ex-dividend date was Thursday, March 5th. Cigna Group's payout ratio is currently 28.13%.
Wall Street Analysts Forecast Growth
Several research analysts recently commented on the stock. Piper Sandler reduced their price objective on shares of Cigna Group from $374.00 to $370.00 and set an "overweight" rating for the company in a research note on Tuesday, March 3rd. Leerink Partners boosted their price objective on shares of Cigna Group from $270.00 to $297.00 and gave the stock a "market perform" rating in a research note on Friday, February 6th. Truist Financial boosted their price objective on shares of Cigna Group from $320.00 to $350.00 and gave the stock a "buy" rating in a research note on Tuesday, February 17th. Barclays reduced their price objective on shares of Cigna Group from $305.00 to $303.00 and set an "overweight" rating for the company in a research note on Friday, February 6th. Finally, Sanford C. Bernstein raised shares of Cigna Group from a "market perform" rating to an "outperform" rating and raised their price target for the stock from $307.00 to $358.00 in a report on Thursday, March 12th. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $333.11.
Read Our Latest Research Report on Cigna Group
Insider Transactions at Cigna Group
In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the company's stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Everett Neville sold 1,719 shares of the company's stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares of the company's stock, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.60% of the company's stock.
Cigna Group Profile
(
Free Report)
Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report